Pacira BioSciences, Inc. (PCRX)
USD 22.34
(-3.29%)
USD 22.34
(-3.29%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.57 Billion USD | -6.35% |
| 2022 | 1.68 Billion USD | -18.99% |
| 2021 | 2.07 Billion USD | 62.83% |
| 2020 | 1.27 Billion USD | 53.36% |
| 2019 | 831.06 Million USD | 20.56% |
| 2018 | 689.35 Million USD | 9.7% |
| 2017 | 628.37 Million USD | 60.52% |
| 2016 | 391.46 Million USD | 0.47% |
| 2015 | 389.62 Million USD | 19.49% |
| 2014 | 326.07 Million USD | 92.01% |
| 2013 | 169.82 Million USD | 51.55% |
| 2012 | 112.05 Million USD | -1.27% |
| 2011 | 113.49 Million USD | 70.5% |
| 2010 | 66.56 Million USD | 51.44% |
| 2009 | 43.95 Million USD | -13.03% |
| 2008 | 50.54 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.58 Billion USD | 0.57% |
| 2024 Q2 | 1.64 Billion USD | 4.01% |
| 2023 Q1 | 1.52 Billion USD | -9.39% |
| 2023 Q3 | 1.53 Billion USD | -0.51% |
| 2023 Q2 | 1.54 Billion USD | 1.24% |
| 2023 FY | 1.57 Billion USD | -6.35% |
| 2023 Q4 | 1.57 Billion USD | 2.6% |
| 2022 Q3 | 1.73 Billion USD | 0.02% |
| 2022 Q4 | 1.68 Billion USD | -3.07% |
| 2022 FY | 1.68 Billion USD | -18.99% |
| 2022 Q1 | 1.89 Billion USD | -8.86% |
| 2022 Q2 | 1.73 Billion USD | -8.33% |
| 2021 Q3 | 1.35 Billion USD | 2.28% |
| 2021 FY | 2.07 Billion USD | 62.83% |
| 2021 Q1 | 1.28 Billion USD | 1.02% |
| 2021 Q4 | 2.07 Billion USD | 53.05% |
| 2021 Q2 | 1.32 Billion USD | 2.97% |
| 2020 Q1 | 821.37 Million USD | -1.17% |
| 2020 Q2 | 866.11 Million USD | 5.45% |
| 2020 Q3 | 1.22 Billion USD | 40.89% |
| 2020 Q4 | 1.27 Billion USD | 4.45% |
| 2020 FY | 1.27 Billion USD | 53.36% |
| 2019 Q3 | 807.48 Million USD | 2.49% |
| 2019 Q4 | 831.06 Million USD | 2.92% |
| 2019 Q2 | 787.84 Million USD | 9.55% |
| 2019 Q1 | 719.15 Million USD | 4.32% |
| 2019 FY | 831.06 Million USD | 20.56% |
| 2018 Q4 | 689.35 Million USD | 4.6% |
| 2018 FY | 689.35 Million USD | 9.7% |
| 2018 Q3 | 659.04 Million USD | 2.55% |
| 2018 Q2 | 642.68 Million USD | 3.32% |
| 2018 Q1 | 622.03 Million USD | -1.01% |
| 2017 Q2 | 605.74 Million USD | 0.96% |
| 2017 Q1 | 599.96 Million USD | 53.26% |
| 2017 Q3 | 606.09 Million USD | 0.06% |
| 2017 FY | 628.37 Million USD | 60.52% |
| 2017 Q4 | 628.37 Million USD | 3.68% |
| 2016 FY | 391.46 Million USD | 0.47% |
| 2016 Q1 | 391.2 Million USD | 0.41% |
| 2016 Q3 | 381.15 Million USD | -4.88% |
| 2016 Q4 | 391.46 Million USD | 2.71% |
| 2016 Q2 | 400.69 Million USD | 2.43% |
| 2015 Q1 | 335.03 Million USD | 2.75% |
| 2015 Q4 | 389.62 Million USD | 5.59% |
| 2015 FY | 389.62 Million USD | 19.49% |
| 2015 Q2 | 354.99 Million USD | 5.96% |
| 2015 Q3 | 368.98 Million USD | 3.94% |
| 2014 Q2 | 292.08 Million USD | 78.43% |
| 2014 Q4 | 326.07 Million USD | 6.77% |
| 2014 Q1 | 163.69 Million USD | -3.61% |
| 2014 FY | 326.07 Million USD | 92.01% |
| 2014 Q3 | 305.39 Million USD | 4.56% |
| 2013 Q4 | 169.82 Million USD | -1.49% |
| 2013 FY | 169.82 Million USD | 51.55% |
| 2013 Q3 | 172.39 Million USD | -3.38% |
| 2013 Q2 | 178.43 Million USD | -3.68% |
| 2013 Q1 | 185.24 Million USD | 65.31% |
| 2012 Q4 | 112.05 Million USD | -15.64% |
| 2012 Q1 | 94.26 Million USD | -16.94% |
| 2012 FY | 112.05 Million USD | -1.27% |
| 2012 Q2 | 142.85 Million USD | 51.55% |
| 2012 Q3 | 132.82 Million USD | -7.02% |
| 2011 Q4 | 113.49 Million USD | 46.23% |
| 2011 Q2 | 87.09 Million USD | -11.01% |
| 2011 Q1 | 97.86 Million USD | 47.03% |
| 2011 Q3 | 77.6 Million USD | -10.89% |
| 2011 FY | 113.49 Million USD | 70.5% |
| 2010 Q3 | 52.75 Million USD | 5.01% |
| 2010 FY | 66.56 Million USD | 51.44% |
| 2010 Q4 | 66.56 Million USD | 26.17% |
| 2010 Q2 | 50.24 Million USD | 0.0% |
| 2009 FY | 43.95 Million USD | -13.03% |
| 2009 Q4 | 43.95 Million USD | 0.0% |
| 2008 FY | 50.54 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -2274.798% |
| Safety Shot Inc | 12.7 Million USD | -12287.786% |
| Bright Green Corporation | 17.4 Million USD | -8946.611% |
| Embecta Corp. | 1.21 Billion USD | -29.643% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | -74.076% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -2641.973% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | -37.704% |
| Dynavax Technologies Corporation | 997.09 Million USD | -57.897% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -665.023% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | -116.174% |
| PainReform Ltd. | 9.93 Million USD | -15754.844% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -5657.078% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -5657.078% |
| SCYNEXIS, Inc. | 128.41 Million USD | -1126.043% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -6707.55% |
| Journey Medical Corporation | 76.84 Million USD | -1948.675% |
| Alpha Teknova, Inc. | 128.58 Million USD | -1124.374% |
| Procaps Group, S.A. | 460.18 Million USD | -242.119% |
| Theratechnologies Inc. | 77.76 Million USD | -1924.439% |
| Harrow Health, Inc. | 311.75 Million USD | -405.007% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -10471.315% |
| Biofrontera Inc. | 27.93 Million USD | -5536.496% |
| DURECT Corporation | 45.18 Million USD | -3384.003% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | -11.74% |
| Cronos Group Inc. | 1.13 Billion USD | -38.804% |
| OptiNose, Inc. | 107.72 Million USD | -1361.432% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | -234.213% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -2713.966% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -6731.157% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -242.239% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -13109.957% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -1825.24% |
| Radius Health, Inc. | 1.71 Billion USD | 8.25% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -2854.539% |
| ProPhase Labs, Inc. | 91.92 Million USD | -1612.648% |
| Phibro Animal Health Corporation | 982.18 Million USD | -60.294% |
| Procaps Group S.A. | 460.18 Million USD | -242.119% |
| Alvotech | 950.09 Million USD | -65.709% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -3535.24% |
| Viatris Inc. | 47.68 Billion USD | 96.698% |
| Rockwell Medical, Inc. | 52.17 Million USD | -2917.626% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -1233.152% |
| SIGA Technologies, Inc. | 254.83 Million USD | -517.803% |
| Tilray Brands, Inc. | 4.33 Billion USD | 63.684% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -475.219% |
| Shineco, Inc. | 84.17 Million USD | -1770.275% |
| PetIQ, Inc. | 868.22 Million USD | -81.334% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -18557.817% |
| Incannex Healthcare Limited | 17.04 Million USD | -9135.561% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 51.578% |
| Alimera Sciences, Inc. | 153.52 Million USD | -925.498% |
| Silver Spike Investment Corp. | 88.57 Million USD | -1677.435% |
| Assertio Holdings, Inc. | 286.41 Million USD | -449.679% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -26352.551% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -4558.526% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -4939.164% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -11784.367% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -502.922% |
| Hempacco Co., Inc. | 18.04 Million USD | -8625.705% |
| Talphera, Inc. | 20.39 Million USD | -7619.47% |
| Alvotech | 950.09 Million USD | -65.709% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -287.627% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 4.649% |
| Currenc Group, Inc. | 141.49 Million USD | -1012.716% |
| Kamada Ltd. | 351.96 Million USD | -347.307% |
| Indivior PLC | 1.95 Billion USD | 19.314% |
| Evoke Pharma, Inc. | 7.06 Million USD | -22173.124% |
| Flora Growth Corp. | 23.62 Million USD | -6563.786% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -11784.367% |
| Evolus, Inc. | 188.99 Million USD | -733.017% |
| HUTCHMED (China) Limited | 1.27 Billion USD | -23.021% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | -4.063% |
| Akanda Corp. | 8.83 Million USD | -17709.81% |